Jonathan Allan, General Counsel & Corp Sec: Stoke Therapeutics STOK Sell · Filed 03/24

Trade details

Type: Insider sale
Amount: $20,680.41
Shares · price: 601 sh · $34.41 a share
Held after: 19,543 sh
Stock: Stoke Therapeutics STOK
Person: Jonathan AllanGeneral Counsel & Corp Sec
Trade date: 26/03/20
Filed: 26/03/24
Days to filing: 4 days

Sold 3.0% of holdings

Share of holding sold: 3.0%

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 02/18~04/19

Jonathan Allan's recent trades

Jonathan AllanGeneral Counsel & Corp Sec
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$43.6K
1,457 sh
$43.6K
Filed 06/18
Traded 06/16
Jonathan AllanGeneral Counsel & Corp Sec
Planned sale10b5-1 planStoke Therapeutics
Planned sale10b5-1 plan
Stoke Therapeutics
STOK
$43.7K
1,457 sh
$43.7K
Filed 06/16
Traded 06/16
Jonathan AllanGeneral Counsel & Corp Sec
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$292.4K
8,692 sh
$292.4K
Filed 03/24
Traded 03/20
Jonathan AllanGeneral Counsel & Corp Sec
Planned sale10b5-1 planStoke Therapeutics
Planned sale10b5-1 plan
Stoke Therapeutics
STOK
$308.4K
9,293 sh
$308.4K
Filed 03/20
Traded 03/20
Jonathan AllanGeneral Counsel & Corp Sec
SellStoke Therapeutics
Sell
Stoke Therapeutics
STOK
$132.1K
4,222 sh
$132.1K
Filed 03/19
Traded 03/18

Jonathan Allan, General Counsel — sold $20.7K of Stoke Therapeutics STOK · 3.0% of holdings · 10b5-1 plan | Whalegun